Factor V Leiden: to test or not to test, that is the debate.
作者信息
Makris Mike
出版信息
Blood Transfus. 2012 Jul;10(3):255-6. doi: 10.2450/2012.0108-12.
Abstract
摘要
相似文献
1
Factor V Leiden: to test or not to test, that is the debate.
Blood Transfus. 2012 Jul;10(3):255-6. doi: 10.2450/2012.0108-12.
2
Utility of testing for factor V Leiden.
Blood Transfus. 2012 Jul;10(3):257-9. doi: 10.2450/2012.0095-12.
3
Coagulation factor V and thrombophilia: background and mechanisms.
Thromb Haemost. 2007 Sep;98(3):530-42.
4
Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm.
Arch Pathol Lab Med. 2002 May;126(5):577-82. doi: 10.5858/2002-126-0577-APCRTF.
5
Futility of testing for factor V Leiden.
Blood Transfus. 2012 Jul;10(3):260-3. doi: 10.2450/2012.0097-12.
6
Activated protein C resistance, factor V Leiden, and retinal vessel occlusion.
Retina. 1998;18(4):297-300. doi: 10.1097/00006982-199807000-00001.
7
Thrombo-embolic disease--prevalence of factor V Leiden in the Western Cape.
S Afr Med J. 2001 May;91(5):406.
8
Activated protein C resistance (FV(Leiden)) and thrombosis: factor V mutations causing hypercoagulable states.
Hematol Oncol Clin North Am. 2003 Feb;17(1):37-61, vi. doi: 10.1016/s0889-8588(02)00097-7.
9
10
Factor V mutations in Iranian patients with activated protein C resistance and venous thrombosis.
Thromb Res. 2007;119(2):189-93. doi: 10.1016/j.thromres.2006.02.001. Epub 2006 Mar 15.
引用本文的文献
1
Acute pulmonary thromboembolism caused by factor V Leiden mutation in South Korea: A case report.
Medicine (Baltimore). 2019 Jul;98(28):e16318. doi: 10.1097/MD.0000000000016318.
本文引用的文献
1
Futility of testing for factor V Leiden.
Blood Transfus. 2012 Jul;10(3):260-3. doi: 10.2450/2012.0097-12.
2
Utility of testing for factor V Leiden.
Blood Transfus. 2012 Jul;10(3):257-9. doi: 10.2450/2012.0095-12.
3
Clinical guidelines for testing for heritable thrombophilia.
Br J Haematol. 2010 Apr;149(2):209-20. doi: 10.1111/j.1365-2141.2009.08022.x. Epub 2010 Jan 28.
4
American College of Medical Genetics consensus statement on factor V Leiden mutation testing.
Genet Med. 2001 Mar-Apr;3(2):139-48. doi: 10.1097/00125817-200103000-00009.
5
Familial thrombophilia: genetic risk factors and management.
J Intern Med Suppl. 1997;740:9-15.
6
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1004-8. doi: 10.1073/pnas.90.3.1004.
7
Mutation in blood coagulation factor V associated with resistance to activated protein C.
Nature. 1994 May 5;369(6475):64-7. doi: 10.1038/369064a0.
Zotero 插件